Concepedia

R. Eric Davis

RE

Statistics

Publications

4

Citations

10.4K

H-Index

4

Active since

2000

Affiliations

National Institutes of Health(Current)

National Cancer Institute

R. Eric Davis is an author at National Institutes of Health specializing in oncology, life sciences, and molecular oncology.

Publications per year

2000–2017

4

Publications

4

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

Ash A. Alizadeh, Michael B. Eisen, R. Eric Davis et al. · Nature · 2000 · 10K citations

Life Sciences, Molecular Biology, Oncology +12

Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol

Lloyd T. Lam, Oxana K. Pickeral, A Peng et al. · Genome biology · 2001 · 373 citations · Full text

Life Sciences, Oncology, Pharmacology +15

Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients

Joseph Gligorov, Beyhan Ataseven, Mark Verrill et al. · European Journal of Cancer · 2017 · 46 citations · Full text

Medicine, Oncology, Pharmacology +17

HIGH RESPONSE RATES WITH PEMBROLIZUMAB IN COMBINATION WITH RITUXIMAB IN PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA: INTERIM RESULTS OF AN ON OPEN‐LABEL, PHASE II STUDY

L. Nastoupil, Jason R. Westin, Nathan Fowler et al. · Hematological Oncology · 2017 · 12 citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

1–4 of 4